Related Experiment Videos
Comparative effectiveness. Federal government's push for more data to benefit supply chain.
Materials Management in Health Care
|May 15, 2010
Summary
The American Recovery and Reinvestment Act of 2009 funded comparative effectiveness research to compare treatments for conditions. Findings will inform healthcare supply chains about medical device and implant performance.
Area of Science:
- Health economics
- Health services research
- Medical device research
Background:
- The American Recovery and Reinvestment Act of 2009 allocated $1.1 billion towards comparative effectiveness research.
- This funding supports studies comparing the efficacy of different medical treatments, including drugs, devices, and procedures for specific conditions.
Purpose of the Study:
- To examine the comparative effectiveness of medical interventions.
- To explore the implications of this research for the healthcare supply chain, particularly regarding medical implants.
Main Methods:
- The abstract does not specify the methods used in the studies funded by the Act.
- It focuses on the *purpose* and *potential impact* of comparative effectiveness research.
Main Results:
- The abstract does not present specific findings from completed studies.
- It outlines the *potential* for findings to inform materials managers about product performance.
Conclusions:
- Comparative effectiveness research, funded by the American Recovery and Reinvestment Act, has the potential to significantly impact healthcare supply chain management.
- Understanding the comparative performance of medical products like knee, hip, and spinal implants is a key outcome.
- This movement aims to optimize healthcare resource allocation and product selection.
Related Concept Videos
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...